U-Blot® Research Grade EvunzekibartCat. No. WA2836$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade EvunzekibartCat. No. WA2836
U-Blot® Research Grade EvorpaceptCat. No. WA2835
U-Blot® Research Grade EvolocumabCat. No. WA2834
U-Blot® Research Grade EvinacumabCat. No. WA2833
U-Blot® Research Grade EvalstotugCat. No. WA2832
U-Blot® Research Grade evabosmigCat. No. WA2831
U-Blot® Research Grade EurestobartCat. No. WA2830
U-Blot® Research Grade etuptamigCat. No. WA2829
U-Blot® Research Grade EtrolizumabCat. No. WA2828
U-Blot® Research Grade EtokimabCat. No. WA2827
U-Blot® Research Grade EtigilimabCat. No. WA2826
U-Blot® Research Grade EtevritamabCat. No. WA2825